KU 270 (Oxybutynin chloride extended-release 5 mg)
Pill imprint KU 270 has been identified as Oxybutynin chloride extended-release 5 mg.
Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; dysuria; hyperhidrosis; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for KU 270 (Oxybutynin chloride extended-release 5 mg)
Oxybutynin chloride extended-release
- Imprint:
-
KU
270 - Strength:
- 5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Kremers Urban
- National Drug Code (NDC):
- 62175-0270
- Inactive Ingredients:
- lactose anhydrous
lactose monohydrate
mannitol
tartaric acid
silicon dioxide
magnesium stearate
cellulose acetate
polyethylene glycol
titanium dioxide
triacetin
ferrosoferric oxide
propylene glycol
hypromelloses
More resources
Oxybutynin chloride extended-release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
